Mireille Gingras Gillings, (born 1962) is a US-based Canadian neurobiologist and entrepreneur. She founded HUYA Bioscience International, a biotech consulting firm in 2004, and is the San Diego, California, company's CEO and Executive Chair. The company has offices in Pudong, Shanghai, China.[1][2]
Mireille Gillings | |
|---|---|
 Mireille Gillings | |
| Born | 1962 (age 61–62) |
| Education | |
| Occupation(s) | neurobiologist and entrepreneur |
| Spouse | Sir Dennis Gillings (m. 2012) |
In 2010, Gillings' interest in China as a source of "research-intensive, expensive-to-develop medicines that are the stuff of patents and high profit margins" attracted the interest of Fortune magazine.[3]
Born in Montreal, Quebec, Gillings earned her PhD from Radboud University Nijmegen and has held postdoctoral fellowships at Bordeaux University in France and The Scripps Research Institute in La Jolla, California. She received her bachelor's degree from Montréal's Concordia University.[4]
Also one of the founders of MIR3,[5] she is a "serial entrepreneur", as she has described herself.[6] Gillings is at least functional in several languages, including Mandarin, in addition to her native French.[7]
Philanthropy
editIn 2019 the French Government awarded Dr. Gillings its highest national award, the Knight of the Legion of Honor, in recognition of her contributions to neuroscience, entrepreneurship and philanthropy.[citation needed]
Personal life
editIn 2012, she married Dennis Gillings in Hawaii.[8]
References
edit- ^ Welcome Message from CEO and founder Mireille Gillings, PhD (accessed 6 November 2010)
- ^ Poh, Alissa (13 November 2008). "HUYA: A conduit between Chinese pharma and US clinical trials". PharmaWeek. Archived from the original on 7 May 2010. Retrieved 6 November 2010.
- ^ Powell, Bill (15 November 2010). "Biotech pioneers: How two unlikely partners plan to unleash China's young pharma industry". Fortune. Vol. 182, no. 8. pp. 49–50, 52. Retrieved 6 November 2010. The quotation appears on p. 50.
- ^ "Executive Team - HUYA Bioscience International". Archived from the original on 10 May 2018. Retrieved 14 June 2017.
- ^ HUYA profile on Bloomberg Business Week[dead link] (accessed 6 November 2010); see also the MIR3 site
- ^ Dolgin, Elie (June 2009). "Year of the compound: Will a novel codevelopment model open up China's drug discovery platform?". Scientist. Vol. 23, no. 6. p. 57. Archived from the original on 26 August 2012. Retrieved 6 November 2010. The article explains that the name HUYA comes from the "Chinese abbreviations for Shanghai (Hù) and Asia (Yà)"; the name is pronounced in English like WHO YA with equal stress on both syllables (/'hu·'ja/).
- ^ David, Gollaher; Gingras, Mirielle (9 February 2010). "HUYA Bioscience International". CHI: Advancing California Biomedical Research and Innovation. Retrieved 6 November 2010.
- ^ Gibson, Dale (7 September 2012). "Gillings remarries; new bride heads California pharma". www.bizjournals.com.